Blood is a specialized connective tissue that plays a central role in transport, regulation, and protection within the body. It circulates through a closed system of blood vessels and is essential for maintaining homeostasis.
Plasma is the straw-colored fluid that remains after removal of blood cells. It is ~92% water and serves as the transport medium for nutrients, hormones, and waste.
Component | Percentage/Details | Function |
---|---|---|
Water (92%) | Solvent medium | Maintains volume and transports substances |
Plasma proteins (7%) | Albumin, globulins, fibrinogen | Maintain osmotic pressure, immunity, clotting |
Electrolytes | NaβΊ, KβΊ, CaΒ²βΊ, Clβ», HCOββ» | Acid-base balance, nerve/muscle function |
Nutrients | Glucose, amino acids, lipids | Energy supply and tissue repair |
Gases | Oβ, COβ, Nβ | Cellular respiration and waste elimination |
Waste products | Urea, creatinine, bilirubin | Excreted by kidneys or liver |
Hormones and enzymes | Various | Regulation of physiological processes |
These are the cellular components suspended in plasma, produced primarily in the red bone marrow.
Type | % of WBCs | Function |
---|---|---|
Neutrophils | 60β70% | Phagocytosis of bacteria |
Eosinophils | 2β4% | Combat parasites, allergic response |
Basophils | <1% | Release histamine in inflammation |
Type | % of WBCs | Function |
---|---|---|
Lymphocytes | 20β25% | B and T cells β immunity |
Monocytes | 3β8% | Phagocytosis, become macrophages |
Component | % of Total Volume | Key Function |
---|---|---|
Plasma | ~55% | Transport, pH balance, immunity, clotting |
RBCs | ~44% | Oxygen and COβ transport |
WBCs | <1% | Defense against pathogens |
Platelets | <1% | Hemostasis (clot formation) |
Condition | Blood Composition Change |
---|---|
Anemia | β RBC count/hemoglobin |
Leukocytosis | β WBC count (infection, leukemia) |
Thrombocytopenia | β Platelets (bleeding risk) |
Dehydration | β Hematocrit due to plasma volume loss |
Hyperproteinemia | β Plasma proteins (e.g., in multiple myeloma) |
Hypoproteinemia | β Albumin (malnutrition, liver disease) |
Blood is a complex, multifunctional fluid made of plasma and formed elements. Its composition reflects and affects nearly every aspect of human physiologyβtransport, immunity, clotting, and pH balanceβmaking it central to both health assessment and disease diagnosis.
Blood is a life-sustaining fluid tissue that circulates through the cardiovascular system, delivering substances essential for cellular functions and removing waste products. Its dynamic composition supports multiple physiological systemsβincluding respiratory, immune, excretory, regulatory, and endocrine functions.
Blood performs three main categories of functions:
Blood serves as the primary transport medium in the body.
Blood plays a key role in homeostasis by regulating internal environmental conditions.
The blood helps defend the body against pathogens, injury, and bleeding.
Category | Specific Function |
---|---|
Transport | Oβ, COβ, nutrients, hormones, waste |
Regulation | pH, temperature, osmotic balance, blood volume |
Protection | Immune defense, clotting, wound healing, detox |
Condition | Impaired Function |
---|---|
Anemia | β Oxygen-carrying capacity |
Leukopenia/Leukocytosis | Immune suppression / hyperactivity |
Dehydration | β Plasma volume β hypotension |
Liver failure | β Clotting proteins β bleeding risk |
Sepsis | Disrupted regulation β shock, clotting imbalance |
Blood is not just a transport mediumβit is a multifunctional connective tissue that plays crucial roles in sustaining life, maintaining balance, and defending against harm. For nurses and clinicians, recognizing alterations in these functions is vital for early diagnosis, treatment, and care planning in both acute and chronic illnesses.
Blood is a specialized connective tissue with unique physical properties that allow it to circulate efficiently throughout the vascular system. Its color, volume, viscosity, temperature, and pH contribute to its ability to perform vital transport, regulatory, and protective functions.
π§ Color changes are clinically significant in assessing hypoxia, cyanosis, or carbon monoxide poisoning.
π©Ί Blood volume is crucial in managing fluid therapy, blood transfusions, and shock.
π Clinical Relevance:
π§ Useful in thermoregulation and fever response.
β οΈ Deviations:
(Not typically used in diagnosis but relevant to understanding waste accumulation in renal failure or sepsis.)
Characteristic | Normal Value/Description | Clinical Significance |
---|---|---|
Color | Bright red (oxygenated), dark red (deoxygenated) | Reflects oxygen saturation |
Volume | 4β6 L (avg adult) | Guides fluid replacement, transfusion |
Viscosity | 4β5Γ thicker than water | Affects blood flow and cardiac workload |
Temperature | ~38Β°C (100.4Β°F) | Thermoregulation |
pH | 7.35β7.45 (slightly alkaline) | Buffer function, metabolic and respiratory balance |
Specific gravity | 1.050β1.060 | Relates to cell/plasma content |
Osmotic pressure | ~25 mmHg (colloid pressure) | Maintains fluid balance in capillaries |
The physical properties of blood are essential for its role in circulation, oxygen delivery, waste removal, and regulation of body conditions. These characteristics form the foundation for interpreting clinical symptoms, performing diagnostic tests, and providing targeted care in various health conditions.
Hematopoiesis (or hemopoiesis) is the physiological process by which the body produces blood cells. It occurs continuously throughout life to replenish cells that are used, aged, or lost due to bleeding or disease.
All blood cells originate from pluripotent hematopoietic stem cells in the red bone marrow through a tightly regulated process involving growth factors, cytokines, and cell differentiation.
Life Stage | Primary Sites |
---|---|
Embryonic (first 2 months) | Yolk sac |
Fetal (2β7 months) | Liver and spleen |
Late fetal and after birth | Red bone marrow (sternum, ribs, pelvis, vertebrae, skull, proximal long bones) |
In adults, flat bones are the major hematopoietic sites.
All blood cells arise from hematopoietic stem cells (HSCs), which differentiate into:
Lymphocytes are key players in adaptive immunity.
Cell Type | Origin | Key Hormone | Primary Function |
---|---|---|---|
RBCs | Myeloid stem cell | Erythropoietin | Oβ and COβ transport |
Platelets | Myeloid stem cell | Thrombopoietin | Blood clotting |
Neutrophils | Myeloid stem cell | G-CSF | Phagocytosis of bacteria |
Eosinophils | Myeloid stem cell | GM-CSF | Allergy & parasite defense |
Basophils | Myeloid stem cell | GM-CSF | Release histamine in inflammation |
Monocytes | Myeloid stem cell | M-CSF | Become macrophages; phagocytosis |
B Lymphocytes | Lymphoid stem cell | IL-7 | Antibody production |
T Lymphocytes | Lymphoid stem cell | IL-2, IL-7 | Cell-mediated immunity |
NK Cells | Lymphoid stem cell | IL-15 | Non-specific immune response |
Condition | Effect on Hematopoiesis |
---|---|
Anemia | Decreased erythropoiesis or nutrient deficiency |
Leukemia | Uncontrolled proliferation of abnormal WBCs |
Aplastic anemia | Bone marrow failure (β all cell lines) |
Polycythemia vera | Excess RBC production β β viscosity, clot risk |
Chemotherapy | Suppresses bone marrow β pancytopenia |
Bone marrow transplant | Replaces defective hematopoietic stem cells |
Blood cell formation (hematopoiesis) is a complex, finely regulated process vital for:
Understanding its mechanisms enables healthcare professionals to interpret CBC results, manage blood disorders, and support patients undergoing therapies that affect bone marrow function.
Erythropoiesis is the process of red blood cell (erythrocyte) formation. It occurs in the red bone marrow and is stimulated by hypoxia (low oxygen levels in tissues), which triggers the release of erythropoietin, a hormone produced mainly by the kidneys.
Erythropoiesis involves the transformation of a pluripotent stem cell into a mature RBC over ~5β7 days:
π§ͺ Reticulocyte count (~1β2%) reflects bone marrow activity.
Factor | Role |
---|---|
Erythropoietin | Stimulates proliferation & differentiation |
Iron | Required for hemoglobin synthesis |
Vitamin Bββ & Folate | Needed for DNA synthesis in erythroblasts |
Amino acids & Copper | Support globin and enzyme production |
Function | Explanation |
---|---|
Oxygen transport | Hemoglobin binds Oβ in lungs and releases it in tissues |
Carbon dioxide transport | Carries COβ from tissues to lungs (as carbaminohemoglobin or HCOββ») |
Buffering pH | Hemoglobin acts as a buffer by binding HβΊ and maintaining blood pH |
Maintaining blood viscosity | Contributes to blood flow dynamics and pressure |
Condition | Effect on Erythropoiesis / RBCs |
---|---|
Anemia | β RBCs or hemoglobin β fatigue, pallor |
Polycythemia vera | Excess RBCs β β blood viscosity, clot risk |
Iron-deficiency anemia | Poor hemoglobin synthesis |
Vitamin B12/Folate deficiency | Impaired DNA synthesis β megaloblastic anemia |
Chronic kidney disease | β erythropoietin production β anemia |
Hemolytic anemia | Premature RBC destruction |
Stage | Key Feature | Time |
---|---|---|
Proerythroblast | Large, nucleated cell | Day 1 |
Erythroblast | Hemoglobin starts to form | Days 2β3 |
Normoblast | Nucleus condenses and is expelled | Day 4 |
Reticulocyte | Enters blood, still has RNA | Day 5β6 |
Mature RBC | Fully functional, anucleate | Day 7 |
Lifespan | Circulates, performs functions | ~120 days |
Erythropoiesis is the vital process of red blood cell production, essential for oxygen delivery and acid-base regulation. The mature RBC, though simple in structure, plays a critical role in sustaining life and is a key indicator of many systemic health conditions.
White Blood Cells (WBCs), also known as leukocytes, are the body’s primary defense cells, protecting against infections, foreign bodies, allergens, and abnormal cells (e.g., cancerous cells). Unlike RBCs, WBCs are nucleated, colorless, and capable of movement through tissue spaces.
WBCs are classified into two major groups based on the presence or absence of cytoplasmic granules:
Type | Abundance in Blood | Key Functions |
---|---|---|
Neutrophils | 60β70% | First responders; phagocytose bacteria, fungi |
Eosinophils | 2β4% | Attack parasites; modulate allergic response |
Basophils | <1% | Release histamine in allergies/inflammation |
Type | Abundance in Blood | Key Functions |
---|---|---|
Lymphocytes | 20β25% | Adaptive immunity (B and T cells) |
Monocytes | 3β8% | Differentiate into macrophages; phagocytosis |
Type | Appearance | Key Role |
---|---|---|
Neutrophils | Multi-lobed nucleus, pale granules | Phagocytosis of bacteria |
Eosinophils | Bi-lobed nucleus, red granules | Parasite killing, allergy moderation |
Basophils | Dark purple granules | Histamine release, allergic reactions |
Lymphocytes | Large round nucleus, thin cytoplasm | Adaptive immunity (B, T, NK cells) |
Monocytes | Kidney-shaped nucleus | Phagocytosis, macrophage precursor |
Condition | WBC Change |
---|---|
Bacterial infection | β Neutrophils (Neutrophilia) |
Viral infection | β Lymphocytes (Lymphocytosis) |
Parasitic infection | β Eosinophils (Eosinophilia) |
Allergic reaction | β Basophils and Eosinophils |
Chronic inflammation | β Monocytes (Monocytosis) |
Leukopenia | β Total WBCs (e.g., chemotherapy) |
Leukemia | Uncontrolled WBC production (immature) |
White blood cells are key players in immune surveillance, defense, and tissue repair. Each type has a specialized function, and their levels are crucial indicators in infection, inflammation, immune disorders, and hematologic diseases.
Understanding their types and roles equips healthcare professionals to interpret CBCs, manage immunocompromised patients, and respond to infectious or allergic emergencies.
Platelets, or thrombocytes, are cell fragments that play a crucial role in blood clotting (hemostasis) and wound healing. They are not true cells but are derived from megakaryocytes in the bone marrow.
Feature | Details |
---|---|
Shape | Small, disc-shaped fragments |
Size | ~2β3 Β΅m in diameter |
Count (normal) | 150,000β400,000/Β΅L of blood |
Lifespan | 7β10 days in circulation |
Removal | Cleared by spleen and liver macrophages |
Platelets lack a nucleus, but contain granules with important substances for clotting and tissue repair.
Thrombopoiesis is the process of platelet formation and maturation in the red bone marrow.
Condition | Effect |
---|---|
Thrombocytopenia | Platelet count <150,000/Β΅L β bleeding risk |
Thrombocytosis | Platelet count >400,000/Β΅L β clot risk |
Aspirin/NSAIDs use | Inhibits platelet aggregation |
Leukemia or chemotherapy | Suppressed marrow β low platelet production |
ITP (Immune Thrombocytopenia) | Autoimmune destruction of platelets |
π§ͺ Platelet function tests (e.g., bleeding time, platelet aggregation) help assess clotting ability.
Feature | Detail |
---|---|
Origin | Megakaryocytes in bone marrow |
Hormone Stimulus | Thrombopoietin (TPO) |
Normal Count | 150,000β400,000/ΞΌL |
Lifespan | 7β10 days |
Function | Hemostasis, clot formation, healing |
Clinical Disorders | Thrombocytopenia, thrombocytosis |
Platelets are indispensable for hemostasis, enabling the body to quickly respond to vascular injury and initiate clotting. They also support wound healing and help maintain vascular integrity. Their production (thrombopoiesis) is tightly regulated, and dysfunction can lead to life-threatening bleeding or thrombosis.
Blood clotting (also known as coagulation) is a complex physiological process that prevents excessive blood loss following vascular injury. It involves platelets, clotting factors, vascular endothelium, and fibrin formation.
The clotting process occurs in three phases:
This occurs through two pathways, both leading to activation of Factor X:
β Both pathways converge to activate Factor X, beginning the common pathway.
Pathway | Trigger | Key Factors Involved |
---|---|---|
Intrinsic | Contact with damaged endothelium | XII, XI, IX, VIII, X, V, II, I |
Extrinsic | Tissue trauma (TF release) | VII, X, V, II, I |
Common Pathway | Activation of Factor X | X β Prothrombin β Thrombin β Fibrinogen β Fibrin |
Time taken for blood to form a clot in vitro after being exposed to air.
π©Ί Prolonged clotting time seen in hemophilia, severe liver disease, anticoagulant therapy
Time taken for bleeding to stop from a small skin puncture.
π©Ί Prolonged bleeding time in thrombocytopenia, von Willebrand disease, aspirin use
Time taken for plasma to clot after adding calcium, phospholipid, and an activator.
π©Ί Prolonged PTT in:
Test | Measures | Normal Range | Used For |
---|---|---|---|
Bleeding Time | Platelet function & capillary integrity | 1β6 minutes | von Willebrand disease, aspirin use |
Clotting Time | Coagulation time in whole blood | 5β11 minutes | Hemophilia, liver disease |
PTT / aPTT | Intrinsic & common pathway factors | 25β40 seconds | Monitor heparin, screen hemophilia |
After clot formation:
Condition | Coagulation Profile |
---|---|
Hemophilia A/B | β PTT, normal BT & PT |
Von Willebrand disease | β BT, possibly β PTT |
Liver disease | β CT, PT, PTT due to impaired clotting factor synthesis |
Heparin therapy | β aPTT |
Warfarin therapy | β PT, normal or mildly β aPTT |
The clotting mechanism is a finely regulated cascade involving platelets, clotting factors, and fibrin, ensuring that bleeding stops while maintaining normal circulation. Laboratory tests like BT, CT, and PTT help in diagnosing coagulation disorders, monitoring therapies, and guiding patient management.
Vasoconstriction, also called vascular spasm, is the first immediate response in the process of hemostasisβthe bodyβs way of stopping blood loss after injury to a blood vessel. It is crucial for minimizing blood flow to the damaged area and giving time for platelet plug formation and coagulation to occur.
When a blood vessel is injured, the smooth muscle in the vessel wall contracts. This constriction:
Aspect | Details |
---|---|
What is it? | Constriction of injured blood vessel |
When does it occur? | Immediately after vascular injury |
Why is it important? | Reduces blood loss and prepares for next steps |
Mediators involved | Serotonin, Thromboxane Aβ, Endothelin |
Clinical importance | Aids in surgical bleeding control, trauma care |